Vestcor Inc’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,231
Closed -$94K 1468
2022
Q1
$94K Buy
1,231
+280
+29% +$24.5K ﹤0.01% 1099
2021
Q4
$142K Sell
951
-146
-13% -$22.4K 0.01% 958
2021
Q3
$160K Sell
1,097
-130
-11% -$22.3K 0.01% 903
2021
Q2
$240K Buy
+1,227
New +$222K 0.01% 824

Other funds holding TXG

Vestcor Inc's TXG Position: Q2 2022 in Review

Vestcor Inc sold out of 10x Genomics (TXG) in Q2 2022, closing a stake of 1,231 shares — an estimated $94K sold.

Vestcor Inc first reported a position in TXG in Q2 2021 and held it in 4 quarters. The position peaked at $240K in Q2 2021. 254 funds tracked by Wall St. Rank hold TXG as of Q2 2022.

  • Vestcor Inc reported no remaining 10x Genomics position as of Q2 2022 after selling out during the quarter.
  • Vestcor Inc sold 1,231 10x Genomics shares in Q2 2022, an estimated $94K.
  • Vestcor Inc first reported a position in 10x Genomics in Q2 2021 and held it in 4 quarters.
  • Vestcor Inc's 10x Genomics position peaked at $240K in Q2 2021.
  • 254 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2022.

Based on Vestcor Inc's 13F filing for Q2 2022, filed 15 Aug 2022.